Catabasis Pharmaceuticals, a company focused on clinical-stage drug development that is supported by a pharmacology technology platform pathway, recently announced that…
Articles by Isaura Santos
La Jolla Pharmaceutical Company, a drug development company working on therapies that address life-threatening diseases such as Duchenne…
In 2005, quarterback Vince Young led his teammates from the University of Texas to a coveted national title while…
On May 2, 2015 Bill and Kim Procko will be hosting a skateboarding competition “Carve to CureDuchenne,” which is intended to benefit the nonprofit…
Toronto will come together on Saturday, May 2nd, to make muscles move against muscular dystrophy. Thousands of people suffering with any kind of…
GlobalData recently reported that the global treatment market for Duchenne Muscular Dystrophy will expand in value at a staggering Compound…
Santhera Pharmaceuticals recently announced it received Fast Track designation from the United Stated Food and Drug Administration (FDA) for its Raxone®/Catena® (idebenone)…
BioBlast Pharma Ltd., a clinical-stage biotechnology firm focused on orphan disease treatment solutions, recently announced that its intravenous (IV) solution …
Starting April 1, the public can begin showing their support for Muscular Dystrophy Canada by giving a donation at any of the…
Newport Beach-based charity Coalition Duchenne recently launched an interview series titled “Making a Difference in Duchenne” through its Youtube channel featuring those…